LENZ Therapeutics Inc Defensive Interval Ratio
LENZ Therapeutics Inc defensive interval ratio. LENZ Therapeutics Inc (LENZ) has a Defensive Interval Ratio of 4161 days as of June 2026. Defensive assets of $196.24 Million (cash $-, short-term investments $195.79 Million, receivables $442.00K) cover 4161 days of daily cash needs of $47.16K/day. See LENZ Therapeutics Inc (LENZ) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of LENZ Therapeutics Inc (2022–2025)
Defensive interval ratio of LENZ Therapeutics Inc from 2022 to 2025. This chart shows how LENZ Therapeutics Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 4161 days, meaning defensive assets of $196.24 Million can fund 4161 days of operations without new revenue. Check LENZ Therapeutics Inc (LENZ) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
LENZ Therapeutics Inc Defensive Interval Ratio by Year (2022–2025)
LENZ Therapeutics Inc defensive interval ratio by year from 2022 to 2025. The table below presents the year-by-year Defensive Interval Ratio for LENZ Therapeutics Inc from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see total assets of LENZ Therapeutics Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4644 days | $269.60 Million | $58.05K/day | $- | $267.17 Million | ▼ -1980 days |
| 2024 | 6625 days | $188.87 Million | $28.51K/day | $- | $188.87 Million | ▲ +6021 days |
| 2023 | 604 days | $30.65 Million | $50.72K/day | $- | $30.65 Million | ▼ -7868 days |
| 2022 | 8473 days | $220.50 Million | $26.02K/day | $- | $220.50 Million | — |